Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ELUT

Elutia (ELUT)

Elutia Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ELUT
日付受信時刻ニュースソース見出しコード企業名
2024/11/1507 : 00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
2024/11/1506 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
2024/11/1506 : 05GlobeNewswire Inc.Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025NASDAQ:ELUTElutia Inc
2024/11/1406 : 05GlobeNewswire Inc.Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:ELUTElutia Inc
2024/10/3005 : 05GlobeNewswire Inc.Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024NASDAQ:ELUTElutia Inc
2024/10/2405 : 05GlobeNewswire Inc.Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30NASDAQ:ELUTElutia Inc
2024/10/1519 : 59Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELUTElutia Inc
2024/10/0405 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
2024/09/1821 : 00GlobeNewswire Inc.Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable DevicesNASDAQ:ELUTElutia Inc
2024/09/0705 : 23GlobeNewswire Inc.Elutia Celebrates First YearNASDAQ:ELUTElutia Inc
2024/09/0605 : 05GlobeNewswire Inc.Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and NeurostimulatorsNASDAQ:ELUTElutia Inc
2024/09/0405 : 05GlobeNewswire Inc.Elutia to Participate in Upcoming Investor ConferencesNASDAQ:ELUTElutia Inc
2024/08/1322 : 22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
2024/08/1322 : 22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
2024/08/0805 : 05GlobeNewswire Inc.Elutia Announces Second Quarter 2024 ResultsNASDAQ:ELUTElutia Inc
2024/08/0805 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
2024/08/0205 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
2024/08/0205 : 05GlobeNewswire Inc.Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross ProceedsNASDAQ:ELUTElutia Inc
2024/08/0105 : 05GlobeNewswire Inc.Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of OperationsNASDAQ:ELUTElutia Inc
2024/07/3105 : 05GlobeNewswire Inc.Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024NASDAQ:ELUTElutia Inc
2024/07/1205 : 05GlobeNewswire Inc.Elutia to Present at the Emerging Growth Conference on Thursday, July 18NASDAQ:ELUTElutia Inc
2024/06/1905 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
2024/06/1721 : 30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELUTElutia Inc
2024/06/1721 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
2024/06/1721 : 01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc
2024/06/1721 : 00GlobeNewswire Inc.Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsNASDAQ:ELUTElutia Inc
2024/06/1106 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
2024/06/1106 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
2024/06/1106 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
2024/06/0806 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT

最近閲覧した銘柄

Delayed Upgrade Clock